Pediatric Lung Transplant Outcomes China
- Lung transplantation has revolutionized treatment for adults with end-stage respiratory failure, experiencing significant growth in procedure numbers over recent decades.
- Researchers from Wuxi People's Hospital of Nanjing medical University, The Second Affiliated Hospital of Zhejiang University School of Medicine, and collaborating institutions have undertaken the first thorough nationwide...
- Between 2019 and 2023, a total of 63 pediatric lung transplants were performed on 62 children, ranging in age from 2 to 17 years, across 13 hospitals in...
“`html
Nationwide Study Reveals Insights into Pediatric Lung Transplantation in China
The Challenge of Pediatric Lung Transplantation
Lung transplantation has revolutionized treatment for adults with end-stage respiratory failure, experiencing significant growth in procedure numbers over recent decades. However, pediatric lung transplantation lags behind, hampered by a critical shortage of donors, intricate surgical procedures, and the delicate nature of postoperative recovery in children. Globally, fewer than 3,000 pediatric lung transplants have been performed in the last 30 years, underscoring its rarity. In china, children represent less than 2% of all lung transplant recipients, highlighting the urgent need for dedicated research into pediatric-specific protocols, risks, and outcomes.
First Nationwide Analysis in China
Researchers from Wuxi People’s Hospital of Nanjing medical University, The Second Affiliated Hospital of Zhejiang University School of Medicine, and collaborating institutions have undertaken the first thorough nationwide study of pediatric lung transplantation in China. The retrospective study, leveraging data from the China Lung Transplantation Registry, reviewed all cases performed between 2019 and 2023. Published in the World Journal of Pediatrics on June 3, 2025 (DOI: 10.1007/s12519-025-00916-4), the findings offer crucial insights into patient demographics, surgical techniques, complications, and survival rates, representing a significant step forward in understanding the evolution of pediatric transplantation within China.
Key Findings: Patient Characteristics and Procedures
Between 2019 and 2023, a total of 63 pediatric lung transplants were performed on 62 children, ranging in age from 2 to 17 years, across 13 hospitals in china. The majority of these procedures (95.2%) involved bilateral lung transplants. The primary indication for transplantation was bronchiolitis obliterans syndrome (BOS), accounting for 46% of cases.Other significant indications included cystic fibrosis (12.7%) and idiopathic pulmonary arterial hypertension (11.1%).
Extracorporeal membrane oxygenation (ECMO) was utilized in a ample proportion of patients prior to transplantation, suggesting the severity of illness in this population. Further details regarding ECMO usage and its impact on outcomes are expected to be detailed in the full publication.
| Indication for Transplantation | Percentage of Cases |
|---|---|
| Bronchiolitis Obliterans Syndrome (BOS) | 46% |
| Cystic Fibrosis | 12.7% |
| Idiopathic pulmonary Arterial Hypertension | 11.1% |
| Other | 29.4% |
Implications and Future Directions
This study provides a foundational dataset for understanding the current state of pediatric lung transplantation in China. The relatively low volume of transplants performed highlights the ongoing challenges related to donor availability and the complexity of managing these cases. The high proportion of BOS cases as an indication for transplant suggests a potential need for earlier diagnosis and intervention for this condition.